It is a leucoreduced, allogeneic, pooled, freeze-dried PRP intended to provide a species-specific source of concentrated platelets in plasma for intra-articular administration in dogs and horses.

Researchers from IVIRMA New Jersey, Yale School of Medicine, Yale University, and Acibadem Mehmet Ali Aydinlar University studied how a treatment called platelet-rich plasma (PRP) might help women ...

Morningstar brands and products Company Portfolio ...

Detailed price information for Petvivo Holdings Inc WT (PETVW) from The Globe and Mail including charting and trades.

To significantly minimize safety risks, all dog and horse donors are screened according ... and their ability to treat their patients with PRP”, said Mike Eldred, PetVivo Board Member.